Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10


Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.

Sági JC, Egyed B, Kelemen A, Kutszegi N, Hegyi M, Gézsi A, Herlitschke MA, Rzepiel A, Fodor LE, Ottóffy G, Kovács GT, Erdélyi DJ, Szalai C, Semsei ÁF.

BMC Cancer. 2018 Jul 3;18(1):704. doi: 10.1186/s12885-018-4629-6.


[New and traditional directions in the biology and management of childhood acute lymphoblastic leukemia].

Egyed B, Kovács G, Kutszegi N, Rzepiel A, Csányiné Sági J, Erdélyi DJ, Müller J, Félné Semsei Á.

Orv Hetil. 2018 May;159(20):786-797. doi: 10.1556/650.2018.31059. Review. Hungarian.


HLA-DRB1*07:01-HLA-DQA1*02:01-HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia.

Kutszegi N, Yang X, Gézsi A, Schermann G, Erdélyi DJ, Semsei ÁF, Gábor KM, Sági JC, Kovács GT, Falus A, Zhang H, Szalai C.

Haematologica. 2017 Sep;102(9):1578-1586. doi: 10.3324/haematol.2017.168211. Epub 2017 Jun 8.


[Extracellular vesicles and their role in hematological malignancies].

Rzepiel A, Kutszegi N, Cs Sági J, Kelemen A, Pálóczi K, F Semsei Á, Buzás E, Erdélyi DJ.

Orv Hetil. 2016 Aug;157(35):1379-84. doi: 10.1556/650.2016.30532. Review. Hungarian.


Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma.

Hegyi M, Arany A, Semsei AF, Csordas K, Eipel O, Gezsi A, Kutszegi N, Csoka M, Muller J, Erdelyi DJ, Antal P, Szalai C, Kovacs GT.

Oncotarget. 2017 Feb 7;8(6):9388-9398. doi: 10.18632/oncotarget.11543.


Pharmacogenetics of anthracyclines.

Sági JC, Kutszegi N, Kelemen A, Fodor LE, Gézsi A, Kovács GT, Erdélyi DJ, Szalai C, Semsei ÁF.

Pharmacogenomics. 2016 Jun;17(9):1075-87. doi: 10.2217/pgs-2016-0036. Epub 2016 Jun 8. Review.


Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity.

Kutszegi N, Semsei ÁF, Gézsi A, Sági JC, Nagy V, Csordás K, Jakab Z, Lautner-Csorba O, Gábor KM, Kovács GT, Erdélyi DJ, Szalai C.

PLoS One. 2015 Oct 12;10(10):e0140136. doi: 10.1371/journal.pone.0140136. eCollection 2015.


In interaction with gender a common CYP3A4 polymorphism may influence the survival rate of chemotherapy for childhood acute lymphoblastic leukemia.

Gézsi A, Lautner-Csorba O, Erdélyi DJ, Hullám G, Antal P, Semsei ÁF, Kutszegi N, Hegyi M, Csordás K, Kovács G, Szalai C.

Pharmacogenomics J. 2015 Jun;15(3):241-7. doi: 10.1038/tpj.2014.60. Epub 2014 Sep 30.


Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis.

Lautner-Csorba O, Gézsi A, Erdélyi DJ, Hullám G, Antal P, Semsei ÁF, Kutszegi N, Kovács G, Falus A, Szalai C.

PLoS One. 2013 Aug 5;8(8):e69843. doi: 10.1371/journal.pone.0069843. Print 2013.


Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance.

Lautner-Csorba O, Gézsi A, Semsei AF, Antal P, Erdélyi DJ, Schermann G, Kutszegi N, Csordás K, Hegyi M, Kovács G, Falus A, Szalai C.

BMC Med Genomics. 2012 Sep 28;5:42. doi: 10.1186/1755-8794-5-42.

Supplemental Content

Loading ...
Support Center